Preprint · CC-BY
via OpenAlex
Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD + , Suppresses Glycolysis, TCA Cycle and Cell Growth
Yan Liu, Chengting Luo, Ting Li, Wenhao Zhang, Zhaoyun Zong, Xiaohui Liu, Haiteng Deng
bioRxiv (Cold Spring Harbor Laboratory) · 2020 · ▲ 1 citations
Abstract
Abstract In the present study, we developed a chemical method to produce dihydro nicotinamide mononucleotide (NMNH), which is the reduced-form of nicotinamide mononucleotide (NMN). We demonstrated that NMNH was a better NAD + enhancer compared to NMN both in vitro and in vivo mediated by NMNAT. Additionally, NMNH increased the reduced NAD (NADH) levels in cells and in mouse liver. Metabolomic analysis revealed that NMNH inhibited glycolysis and TCA cycle. In vitro experiments demonstrated that NMNH induced cell cycle arrest and suppressed cell growth. Nevertheless, NMNH treatment did not cause observable difference in mice. Taken together, our work demonstrates that NMNH is a potent NAD + enhancer, and suppresses glycolysis, TCA cycle and cell growth.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2020.11.03.366427
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Liu, Y., Luo, C., Li, T., Zhang, W., Zong, Z., Liu, X., & Deng, H. (2020). Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD + , Suppresses Glycolysis, TCA Cycle and Cell Growth. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2020.11.03.366427
Vancouver
Liu Y, Luo C, Li T, Zhang W, Zong Z, Liu X, et al. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD + , Suppresses Glycolysis, TCA Cycle and Cell Growth. bioRxiv (Cold Spring Harbor Laboratory). 2020. doi:10.1101/2020.11.03.366427.
BibTeX
@unpublished{yan2020Reduce,
title = {Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD + , Suppresses Glycolysis, TCA Cycle and Cell Growth},
author = {Yan Liu and Chengting Luo and Ting Li and Wenhao Zhang and Zhaoyun Zong and Xiaohui Liu and Haiteng Deng},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2020},
doi = {10.1101/2020.11.03.366427},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Proteome Research 2021
Citation only
Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD + and Suppresses Glycolysis, the TCA Cycle, and Cell Growth
Aging Medicine 2021
Open access · CC-BY
Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
EBioMedicine 2023
Open access · CC-BY
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
The FASEB Journal 2021
Open access · CC-BY
Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice
Cell Discovery 2022
Open access · CC-BY
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Biotechnology Journal 2024
Open access · CC-BY